Work

Palivizumab, a Humanized Respiratory Syncytial Virus Monoclonal Antibody, Reduces Hospitalization From Respiratory Syncytial Virus Infection in High-risk Infants

Year: 1998

Type: article

Study designs: Randomized Controlled Trial, Clinical Trial

Source: PEDIATRICS

DOI: 10.1542/peds.102.3.531

Author: The IMpact-RSV Study Group

Language: English

Topic: Respiratory viral infections research

Subfield: Epidemiology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4292315834

FWCI: 38.84

Cites: 8

Cited by: 2,023

Related to: 10